Day: January 4, 2022

BELLEVUE, WA, Jan. 04, 2022 (GLOBE NEWSWIRE) — TraQiQ, Inc. (OTC QB: TRIQ) (the “Company” or “TraQiQ”), a leading provider of last-mile solutions announced today that its subsidiary, MIMO continues to provide much needed employment to people in rural India, helping address a critical need in the market. Data from the Centre for Monitoring Indian Economy (CMIE) shows that rural unemployment is growing and reached 7.91%. “In addition to the published data, there are significant number of people who do not show up in official surveys – many of them do not have a high school education. Employment opportunities for this group, outside of farming, are very limited” said Lathika Regunathan, President of Mimo. MIMO aims to play a dual role for both unemployed rural citizens and enterprises who are looking to fulfil...

VANCOUVER, British Columbia, Jan. 04, 2022 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPD) a clinical stage pharmaceutical development company reports that the Company has granted 96,000 stock options exercisable at $4.10 for five years from date of grant, for officers and directors, employees and a consultant and are subject to approval by regulatory authorities. About Algernon Pharmaceuticals Inc.  Algernon is a drug re-purposing company that investigates safe, already approved drugs, including naturally occurring compounds, for new disease applications, moving them efficiently and safely into new human trials, developing new formulations and seeking new regulatory approvals in global markets. Algernon specifically investigates compounds that have never...

RESEARCH TRIANGLE PARK, N.C., Jan. 04, 2022 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that the Company will participate in two upcoming virtual investor conferences in January.G1’s Chief Executive Officer Jack Bailey and Chief Medical Officer Raj Malik, M.D. will participate in a fireside chat during the H.C. Wainwright BioConnect 2022 conference. The webcast of the fireside chat will become available at 7:00 AM EST on January 10, 2022.On January 12, 2022, at 1:30 PM EST, Mr. Bailey will provide a corporate presentation during the 40th Annual J.P. Morgan Healthcare Conference.The webcast of both events will be accessible on the Events & Presentations page of http://www.g1therapeutics.com. About G1 TherapeuticsG1 Therapeutics, Inc. is a commercial-stage...

MORRISVILLE, N.C., Jan. 04, 2022 (GLOBE NEWSWIRE) — Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success, today announced that Chief Executive Officer Alistair Macdonald is scheduled to present at the 40th Annual J.P. Morgan Healthcare Conference on January 12, 2022, at 10:30 a.m. EST. A webcast of the event, along with a link to the presentation materials and archived audio replay of the presentation, will be available on the Company’s Investor Relations website at investor.syneoshealth.com. About Syneos HealthSyneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success. We lead with a product development mindset, strategically integrating clinical development,...

LAFAYETTE, Colo., Jan. 04, 2022 (GLOBE NEWSWIRE) — urban-gro, Inc. (Nasdaq: UGRO) (“urban-gro” or the “Company”), a fully integrated architectural, engineering and cultivation systems integration company focused on the indoor Controlled Environment Agriculture (“CEA”) market, today announced its participation in the following January investor and trade conferences.CannaCon Northeast, New York, NY, Jan. 7-8: urban-gro will be exhibiting at Booth 526. Sam Andras, EVP of Professional Services, will host a presentation titled “An Architect’s Perspective: Cannabis Facility and Dispensary Design” on Jan. 7 at 12:30 pm ET. 2022 ICR Conference, Virtual, Jan. 10-12: Brad Nattrass, CEO, Dick Akright, CFO, and Dan Droller, EVP of Corporate Development and Investor Relations, will host a presentation on Jan. 10 at 9:30 am ET and participate...

NEW YORK, Jan. 04, 2022 (GLOBE NEWSWIRE) — Virtu Financial, Inc. (NASDAQ: VIRT) (the “Company”) a global market maker, broker and leading provider of global financial services technology, today announced that its subsidiaries commenced marketing of a $1.80 billion senior secured first lien term loan (the “Term Loan”) due in 2029. The proceeds of the Term Loan will be used to repay its existing senior secured term loan in connection with a refinancing of its existing credit facilities, to fund share repurchases under the Company’s authorized repurchase program and for general corporate purposes. The Term Loan will be guaranteed by Virtu Financial LLC, a subsidiary of the Company, and certain of its subsidiaries. Cautionary Note Regarding Forward-Looking Statements This press release contains forward-looking statements. These forward-looking...

LEESBURG, Va., Jan. 04, 2022 (GLOBE NEWSWIRE) — Quantum Computing Inc. (QCI) (Nasdaq: QUBT), a leader in bridging the power of classical and quantum computing, has appointed Michael C. Turmelle to serve on the company’s board of directors. Turmelle brings years of public company executive experience, as well as an extensive background in finance and operations in technology-based companies. He has vast expertise in devising innovative business solutions to successfully deliver profitable outcomes. He has delivered financial and operational leadership across a variety of organizations and markets, and is a proven board member, having served on numerous boards of directors. “I am pleased to be asked to sit on the Board of Directors at Quantum Computing, Inc.” said Turmelle. “The opportunity to work with such a talented team with...